Target Name: OR4F15
NCBI ID: G390649
Review Report on OR4F15 Target / Biomarker Content of Review Report on OR4F15 Target / Biomarker
OR4F15
Other Name(s): olfactory receptor OR15-14 | Olfactory receptor family 4 subfamily F member 15 | O4F15_HUMAN | Olfactory receptor 4F15 | olfactory receptor family 4 subfamily F member 15 | Olfactory receptor OR15-14

OR4F15: A Potential Drug Target and Biomarker for Ovarian Cancer

Ovarian cancer is a leading cause of cancer death in women, with estimates suggesting that in the United States, over 21,000 women will be diagnosed with ovarian cancer this year. Despite advances in treatment, the survival rate for ovarian cancer remains poor, with a five-year survival rate of only 29%. Therefore, there is a significant need for new treatments and biomarkers to improve outcomes for ovarian cancer patients.

One potential drug target for ovarian cancer is the ORF15 gene, located on chromosome 16p13.3. ORF15 is a gene that encodes a protein known as OR15-14, a protein that has been shown to be involved in the development and progression of ovarian cancer. OR15-14 plays a crucial role in the development of ovarian cancer by promoting the growth and survival of cancer cells, and it has also been shown to be overexpressed in ovarian cancer tissues.

In addition to its role in cancer development, OR15-14 has also been shown to be a potential biomarker for ovarian cancer. By measuring the expression of OR15-14 in ovarian cancer tissue samples, researchers have been able to detect the presence of ovarian cancer and monitor its progression over time. This has led to the potential use of OR15-14 as a diagnostic biomarker for ovarian cancer, as well as a target for drug development.

The potential drug target for OR15-14 is centered around the idea that inhibiting its activity can be a effective way to treat ovarian cancer. This is because OR15-14 has been shown to play a crucial role in the growth and survival of ovarian cancer cells, and by blocking its activity, researchers believe they can inhibit the growth of cancer cells and potentially lead to a more effective treatment for ovarian cancer.

One of the key challenges in developing a drug target for OR15-14 is its location on chromosome 16p13.3. This location makes it difficult to identify and target the protein, as the genetic changes that occur in this region are often subtle and difficult to detect. However, researchers have been able to identify a potential drug target for OR15-14 by using a technique called RNA interference. This involves using small pieces of RNA to prevent the production of the protein, and it has been shown to be effective in blocking the activity of OR15-14 in ovarian cancer cells.

Another approach to developing a drug target for OR15-14 is through the use of CRISPR/Cas9 technology. This involves using a tool called CRISPR to make changes to the OR15-14 gene, and then using a protein called Cas9 to cut the changes out of the gene. This allows researchers to make specific and targeted changes to the OR15-14 gene, and it has been shown to be effective in blocking the activity of OR15-14 in ovarian cancer cells.

While the development of a drug target for OR15-14 is an promising step forward in the fight against ovarian cancer, there are still several challenges that must be overcome. For example, it is not clear what the full range of effects of OR15-14 is, or how it interacts with other genes in the body. Additionally, while the use of RNA interference and CRISPR/Cas9 technology has shown promise in blocking the activity of OR15-14, it is not yet clear how these techniques can be used in a clinical setting.

Despite these challenges, the potential drug target for OR15-14 is an exciting area of research that holds great promise for the treatment of ovarian cancer. Further studies are needed to fully understand the activity of OR15-14 and its potential as a drug target

Protein Name: Olfactory Receptor Family 4 Subfamily F Member 15

Functions: Odorant receptor

The "OR4F15 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about OR4F15 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

OR4F16 | OR4F17 | OR4F21 | OR4F29 | OR4F3 | OR4F4 | OR4F5 | OR4F6 | OR4G3P | OR4K1 | OR4K13 | OR4K14 | OR4K15 | OR4K17 | OR4K2 | OR4K5 | OR4K6P | OR4K7P | OR4L1 | OR4M1 | OR4M2 | OR4M2-OT1 | OR4N2 | OR4N3P | OR4N4 | OR4N5 | OR4P4 | OR4Q3 | OR4S1 | OR4S2 | OR4T1P | OR4V1P | OR4X1 | OR4X2 | OR51A1P | OR51A2 | OR51A3P | OR51A4 | OR51A6P | OR51A7 | OR51B2 | OR51B4 | OR51B5 | OR51B6 | OR51C1P | OR51D1 | OR51E1 | OR51E2 | OR51F1 | OR51F2 | OR51G1 | OR51G2 | OR51H1 | OR51I1 | OR51I2 | OR51J1 | OR51L1 | OR51M1 | OR51Q1 | OR51S1 | OR51T1 | OR51V1 | OR52A1 | OR52A4P | OR52A5 | OR52B2 | OR52B4 | OR52B6 | OR52D1 | OR52E1 | OR52E2 | OR52E4 | OR52E5 | OR52E6 | OR52E8 | OR52H1 | OR52I1 | OR52I2 | OR52J3 | OR52K1 | OR52K2 | OR52K3P | OR52L1 | OR52M1 | OR52N1 | OR52N4 | OR52N5 | OR52R1 | OR52W1 | OR52Z1P | OR56A1 | OR56A3 | OR56A4 | OR56A5 | OR56B1 | OR56B4 | OR5A1 | OR5A2 | OR5AC1 | OR5AC2